Zimmer Biomet
Zimmer Biomet Holdings, Inc., commonly referred to as Zimmer Biomet, is a leading global medical device company headquartered in the United States. Founded in 1927, the company has established itself as a key player in the orthopaedics and musculoskeletal health industry, with a strong presence in North America, Europe, and Asia-Pacific. Zimmer Biomet specialises in the design, manufacture, and marketing of innovative products for joint reconstruction, trauma, spine, and dental applications. Their core offerings, including advanced surgical instruments and biologics, are distinguished by their commitment to enhancing patient outcomes and improving surgical efficiency. With a robust portfolio and a reputation for quality, Zimmer Biomet has achieved significant milestones, positioning itself as a trusted partner in the healthcare community. The company continues to lead the market through its dedication to research and development, ensuring it remains at the forefront of medical technology advancements.
DitchCarbon Score
How does Zimmer Biomet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zimmer Biomet's score of 41 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zimmer Biomet's reported carbon emissions
In 2023, Zimmer Biomet reported approximately 82,993 tonnes CO2e in total market-based emissions, comprising about 10,615 tonnes CO2e from Scope 1 and about 72,379 tonnes CO2e from Scope 2. This marks a significant reduction from previous years, with emissions of about 89,801 tonnes CO2e in 2022 and approximately 142,176 tonnes CO2e in 2021. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 55% by 2030, using 2017 as the base year. Additionally, Zimmer Biomet is committed to reducing absolute Scope 3 emissions from purchased goods and services by 15% by 2030, with 2019 as the reference year. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Overall, Zimmer Biomet's proactive approach to managing its carbon footprint reflects its commitment to sustainability and responsible corporate practices within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zimmer Biomet is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
